SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-000415
Filing Date
2022-01-06
Accepted
2022-01-06 09:49:40
Documents
1
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164148056693028.html 4  
1 FORM 4 wf-form4_164148056693028.xml 4 5406
  Complete submission text file 0001628280-22-000415.txt   6904
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDMARK INFRASTRUCTURE PARTNERS LP 2141 ROSECRANS AVENUE, SUITE 2100 EL SEGUNDO CA 90245
Business Address
BROWN JAMES F (Reporting) CIK: 0001624379 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 22513824